Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAY 1007626 IUS for contraception
NCT02490774Phase 2Terminated
- Sponsor
- Bayer
- Start
- Jun 2015
- Primary completion
- May 2016
- Modality
- Peptides, Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of bay-1007626 in contraception, sponsored by Bayer. Started Jun 2015; status: terminated.
02
Drugs
bay-1007626
03
Conditions
contraception
Beyond the preview
Go deeper on NCT02490774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02490774.